{"nctId":"NCT00691600","briefTitle":"Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage","startDateStruct":{"date":"2007-12"},"conditions":["Abscess"],"count":23,"armGroups":[{"label":"oral trimethoprim/sulfamethoxazole","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: oral trimethoprim/sulfamethoxazole"]},{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"oral trimethoprim/sulfamethoxazole","otherNames":["TMP/SMX"]},{"name":"Placebo","otherNames":["Placebo caps"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1.) Abscess \\< 5 cm (\\< 5 cm of induration and fluctuance) requiring incision and drainage 2.) Age \\> 90 days and \\< 18 years 3.) Abscess on the trunk, scalp, extremities, or axillae\n\nExclusion Criteria:\n\n1. Multiple abscesses\n2. Abscess located on the hands, face, or perineum\n3. Abscess as a result of a bite wound\n4. Immunocompromised patient - i.e., diabetes, sickle cell, chronic steroid therapy (\\> 10 days), etc.\n5. Previously failed 48 hours or greater therapy on any antibiotic regimen 6.) Drug allergy to TMP/SMX\n\n7.) Fever \\> or = 102.2 degrees Fahrenheit in the previous 24 hours 8.) Systemic symptoms on presentation - i.e., nausea , vomiting, persistent tachycardia, hypotension, diaphoresis, etc.\n\n9.) Signs /symptoms of another infection or illness - i.e., influenza, croup, etc.","healthyVolunteers":false,"sex":"ALL","minimumAge":"90 Days","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Abscess Resolution","description":"Outcomes will be measured by resolution of size, tenderness, and induration with erythema by parental report 7 - 10 days after initial visit to the Emergency Center","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Requiring Admission for Failure of Abscess Resolution","description":"Percentage of patients requiring admission to Texas Children's or another hospital within 10 days of incision and drainage","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Requiring New or Modified Antibiotics for Failure of Abscess to Resolve","description":"For the antibiotic arm, we determined if the child was prescribed a different antibiotic.\n\nFor the placebo arm, we determined if the child received a prescription for an antibiotic at a subsequent visit (e.g., in the emergency department, by their pediatrician, etc) within 10 days of incision and drainage","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}}